Core Viewpoint - QScreen AI Inc. has officially changed its name from Predictmedix AI Inc. to better reflect its evolution into a broader screening and decision-intelligence platform, enhancing its market positioning and technology alignment [1][5][7]. Company Overview - QScreen AI Inc. is a provider of rapid health screening and remote patient care solutions globally, utilizing AI-powered Smarthealth AI stations to analyze physiological data and predict various health issues [8]. Name Change Details - The company's common shares will begin trading under the new symbol (CSE: QAI) on the Canadian Securities Exchange starting January 27, 2026, with no changes to share capital, business operations, or management [2][3][4]. Technological Evolution - The transition to QScreen AI Inc. signifies the company's advancement beyond traditional AI architectures, incorporating quantum-inspired and advanced computational techniques to enhance data processing and analysis [6][7]. Strategic Focus - The company aims to commercialize advanced, quantum-enhanced AI capabilities across healthcare, safety, and other high-value markets, with a focus on scaling and market penetration [7].

Core Insights - Predictmedix AI Inc. has been selected for the Official Canada Trade Mission to Mexico, highlighting its status as a leader in AI-enabled health and safety technology [1][4][11] Group 1: Trade Mission Details - The trade mission is scheduled for February 15–20, 2026, focusing on key cities such as Mexico City, Guadalajara, and Monterrey [1] - This elite delegation includes only the most export-ready Canadian innovators, aligning with Canada's strategic priorities for global commercial alliances [2] - The mission is led by the Honourable Dominic LeBlanc, Minister responsible for Canada-U.S. Trade, and aims to provide access to Mexican business leaders and government decision-makers [3] Group 2: Strategic Importance - Participation in the trade mission validates Predictmedix's commercial maturity and international market appeal [4][11] - The mission supports Canada's national agenda for export diversification and innovation leadership, coinciding with growing economic momentum with Mexico [6] - Mexico's market, with over 130 million people, offers tariff-free access under CUSMA, making it an ideal location for technology deployment [5] Group 3: Technological Advancements - Predictmedix is emphasizing its integration of quantum-inspired algorithms into its AI framework, enhancing data processing speeds and diagnostic precision [7][9] - The company is onboarding industry veterans to lead its regional distribution network, leveraging their relationships in Mexico's healthcare and industrial sectors [10] Group 4: Commercial Objectives - The mission aims to expand Predictmedix's international sales pipeline and secure high-impact distribution partners [8] - The company is positioned to capitalize on high-growth sectors such as advanced manufacturing, ICT and AI, cleantech, and clean energy [6]

Core Viewpoint - Predictmedix AI Inc. has successfully closed the final tranche of its non-brokered private placement, raising a total of $612,650 across all tranches, indicating strong investor interest and strategic alignment with long-term goals [2][3][5]. Group 1: Financial Details - In the final tranche, the company issued 3,050,000 units at a price of $0.05 per unit, resulting in gross proceeds of $152,500 [3][4]. - The total capital raised from all tranches of the offering amounts to $612,650 [3]. Group 2: Warrant Information - Each unit consists of one common share and one half of a common share purchase warrant, with each warrant allowing the purchase of one half common share at a price of C$0.15 for 36 months [4]. - If the volume weighted average price of the common shares reaches or exceeds $0.30 for 10 consecutive trading days, the company may accelerate the expiry date of the warrants [4]. Group 3: Strategic Approach - The company emphasized a disciplined, value-focused approach to the financing, prioritizing strategic contributions from investors over merely maximizing capital [5]. - The completion of this financing is expected to provide clarity and momentum for advancing initiatives in key markets [5]. Group 4: Company Overview - Predictmedix AI Inc. is an emerging provider of rapid health screening and remote patient care solutions, utilizing AI technology to analyze physiological data and predict health issues [6]. - The company's Smarthealth AI stations can assess 19 physiological vital parameters and detect impairments due to drugs, alcohol, fatigue, or mental illnesses [6].